Patterns of acetaminophen use exceeding 4 grams daily in a hospitalized population at a tertiary care center.

Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review. Expert Rev Gastroenterol Hepatol (2015) 0.92

N-Acetyl cysteine does not prevent liver toxicity from chronic low-dose plus subacute high-dose paracetamol exposure in young or old mice. Fundam Clin Pharmacol (2016) 0.75

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA (2006) 3.49

Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev (2012) 2.76

UK legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ (2004) 2.11

Paracetamol: are therapeutic doses entirely safe? Lancet (2006) 2.07

The German hospital malnutrition study. Clin Nutr (2006) 1.93

Prevalence of malnutrition in nonsurgical hospitalized patients and its association with disease complications. Am J Clin Nutr (1997) 1.84

The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients--a multicenter randomized study. BMC Med (2007) 1.69

Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity. Mol Med (2010) 1.54

Energy deficit and length of hospital stay can be reduced by a two-step quality improvement of nutrition therapy: the intensive care unit dietitian can make the difference. Crit Care Med (2012) 1.53

Hepatotoxicity due to repeated intake of low doses of paracetamol. J Intern Med (1992) 1.46

Paracetamol-induced hepatotoxicity at recommended dosage. J Intern Med (2003) 1.44

Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity. Gut (1988) 1.39

Acetaminophen safety and hepatotoxicity--where do we go from here? Expert Opin Drug Saf (2007) 1.36

Therapeutic misadventure with paracetamol: fact or fiction? Am J Ther (2000) 1.27

Acetaminophen-cysteine adducts during therapeutic dosing and following overdose. BMC Gastroenterol (2011) 1.26

Paracetamol, alcohol and the liver. Br J Clin Pharmacol (2000) 1.19

Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. Ann Intern Med (1986) 1.12

A randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcohol. Aliment Pharmacol Ther (2007) 1.12

Prevalence of malnutrition in 1760 patients at hospital admission: a controlled population study of body composition. Clin Nutr (2003) 1.10

Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans. Clin Pharmacol Ther (2010) 1.08

Severe hepatotoxicity after therapeutic doses of acetaminophen. Clin Ther (2006) 1.07

Does therapeutic use of acetaminophen cause acute liver failure? Pharmacotherapy (2007) 1.02

Apparent potentiation of acetaminophen hepatotoxicity by alcohol. Ann Intern Med (1980) 0.96

Treatment of pain or fever with paracetamol (acetaminophen) in the alcoholic patient: a systematic review. Am J Ther (2000) 0.93

Abnormal serum transaminases following therapeutic doses of acetaminophen in the absence of known risk factors. Dig Dis Sci (1995) 0.90

Prevalence of current DSM-IV alcohol use disorders in short-stay, general hospital admissions, United States, 1994. Arch Intern Med (2003) 0.90

Acetaminophen: old drug, new warnings. Cleve Clin J Med (2010) 0.89

Decrease in cytochrome P4502E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase. Alcohol Clin Exp Res (1995) 0.88

Acute liver failure following therapeutic paracetamol administration in patients with muscular dystrophies. Anaesthesia (2008) 0.84

Acetaminophen hepatotoxicity in the alcoholic. South Med J (1990) 0.83

Influence of smoking and alcohol consumption on admissions and duration of hospitalization. Eur J Public Health (2009) 0.82

Severe idiosyncratic acute hepatic injury caused by paracetamol. J Hepatol (1998) 0.82

Physical health and drinking among medical inpatients with unhealthy alcohol use: a prospective study. Alcohol Clin Exp Res (2010) 0.82

Acute hepatic and renal toxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency. Hepatology (1994) 0.81

Predictors for achieving protein and energy requirements in undernourished hospital patients. Clin Nutr (2011) 0.80

Mild hepatitis at recommended doses of acetaminophen in patients with evidence of constitutionally enhanced cytochrome P450 system activity. J Clin Pharm Ther (2008) 0.79

Severe liver damage caused by therapeutic doses of acetaminophen. Acta Med Scand (1987) 0.79

Therapeutic dose of acetaminophen may induce fulminant hepatitis in the presence of risk factors: a report of two cases. Br J Anaesth (2009) 0.78

Paracetamol hepatotoxicity at therapeutic doses. J Intern Med (2003) 0.77

Apparent potentiation of hepatotoxicity from small doses of acetaminophen by phenobarbital. Ann Intern Med (1984) 0.77

Toxicity of chronic paracetamol ingestion. Aliment Pharmacol Ther (2007) 0.77

Idiosyncratic acute hepatitis caused by paracetamol in two patients with melanoma treated with high-dose interferon-alpha. Ann Intern Med (2001) 0.76

Hepatotoxicity possibly due to paracetamol with carbamazepine. Intern Med J (2004) 0.76